Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-25

Clinical Trial Update: Psilocybin Therapy for Depression in Bipolar II Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating psilocybin therapy for depression in Bipolar II Disorder is currently active but not recruiting, sponsored by the University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Bipolar II Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING